Why the study?
Does ACE phenotyping explain interindividual variability in blood pressure response to ACE inhibitors in patients with hypertension?
Does ACE phenotyping explain interindividual variability in blood pressure response to ACE inhibitors in patients with hypertension?
ACE phenotyping reveals conformational and kinetic changes that may explain resistance to ACE inhibitors in nonresponders, though initial ACE levels do not predict blood pressure reduction.
No takes yet. Share an insight, caveat, or question.
May improve ACEI response prediction over genotyping; extends genetic studies toward phenotypic personalization in CV therapy.
Danilov et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: